Facile preparation of water soluble curcuminoids extracted from turmeric (Curcuma longa L.) powder by using steviol glucosides

Food Chemistry

Volumn 214, Issue , 2017, Pages 366-373

  Nguyen, Thi Thanh Hanh ^a   Si, Jinbeom ^a   Kang, Choongil ^b   Chung, Byoungsang ^b   Chung, Donghwa ^a   Kim, Doman ^a  

^a Seoul National University   (South Korea)

^b OTTOGI Corporation   (South Korea)

Author keywords

Curcuminoids; Rebaudioside A; Solubilization; Steviol glucoside; Stevioside; Turmeric

Indexed keywords

BIOCHEMISTRY; CARBOHYDRATES; FOOD PRODUCTS; SOLUBILITY; VIRUSES;

CURCUMINOIDS; REBAUDIOSIDE-A; SOLUBILIZATION; STEVIOL; STEVIOSIDES; TURMERIC;

EXTRACTION;

CURCUMIN; CURCUMINOID; PLANT GLYCOSIDE; REBAUDIOSIDE A; STEVIOL GLUCOSIDE; STEVIOSIDE; TURMERIC; UNCLASSIFIED DRUG; WATER; GLUCOSIDE; KAURANE DERIVATIVE; PLANT EXTRACT; STEVIOL; TURMERIC EXTRACT;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CURCUMA LONGA; DENGUE VIRUS 4; FLUORESCENCE; IC50; NONHUMAN; PARTICLE SIZE; PH; SPECTROPHOTOMETRY; THIN LAYER CHROMATOGRAPHY; CHEMISTRY; CURCUMA;

CURCUMA; CURCUMIN; DITERPENES, KAURANE; GLUCOSIDES; PLANT EXTRACTS;

EID: 84978431965     PISSN: 03088146     EISSN: 18737072     Source Type: Journal    
DOI: 10.1016/j.foodchem.2016.07.102     Document Type: Article

References (40)

1. Aditya, N.P., Shim, M., Lee, I., Lee, Y., Im, M.H., Ko, S., Curcumin and genistein coloaded nanostructured lipid carriers: In vitro digestion and antiprostate cancer activity. Journal of Agriculture and Food Chemistry 61 (2013), 1878–1883.
2. Ahsan, H., Parveen, N., Khan, N.U., Hadi, S.M., Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. Chemico-Biological Interactions 121 (1999), 161–175.
3. Anand, P., Thomas, S.G., Kunnumakkara, A.B., Sundaram, C., Harikumar, K.B., Sung, B.,.. Aggarwal, B.B., Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochemical Pharmacology 76 (2008), 1590–1611.
4. Anto, R.J., George, J., Babu, K.V., Rajasekharan, K.N., Kuttan, R., Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoids. Mutation Research-Genetic Toxicology 370 (1996), 127–131.
5. Chen, T.Y., Chen, D.Y., Wen, H.W., Ou, J.L., Chiou, S.S., Chen, J.M.,.. Hsu, W.L., Inhibition of enveloped vruses infectivity by curcumin. PLoS ONE, 8, 2013, e62482.
6. Chen, X., Zou, L.Q., Niu, J., Liu, W., Peng, S.F., Liu, C.M., The stability, sustained release and cellular antioxidant activity of curcumin nanoliposomes. Molecules 20 (2015), 14293–14311.
7. Cheng, A.L., Hsu, C.H., Lin, J.K., Hsu, M.M., Ho, Y.F., Shen, T.S.,.. Hsieh, C.Y., Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Research 21 (2001), 2895–2900.
8. Collett, G.P., Campbell, F.C., Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells. Carcinogenesis 25 (2004), 2183–2189.
9. Davis, M.E., Brewster, M.E., Cyclodextrin-based pharmaceutics: Past, present and future. Nature Reviews Drug Discovery 3 (2004), 1023–1035.
10. Devasena, T., Rajasekaran, K.N., Gunasekaran, G., Viswanathan, P., Menon, V.P., Anticarcinogenic effect of bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione a curcumin analog on DMH-induced colon cancer model. Pharmacological Research 47 (2003), 133–140.
11. Goel, A., Kunnumakkara, A.B., Aggarwal, B.B., Curcumin as “Curecumin”: From kitchen to clinic. Biochemical Pharmacology 75 (2008), 787–809.
12. Gopal, J., Muthu, M., Chun, S.C., One-step, ultrasonication-mobilized, solvent-free extraction/synthesis of nanocurcumin from turmeric. RSC Advances 5 (2015), 48391–48398.
13. Ireson, C.R., Jones, D.J., Orr, S., Coughtrie, M.W., Boocock, D.J., Williams, M.L.,.. Gescher, A.J., Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiology Biomarkers Prevention 11 (2002), 105–111.
14. Ji, J.L., Huang, X.F., Zhu, H.L., Curcumin and its formulations: Potential anti-cancer agents. Anticancer Agents Medicinal Chemistry 12 (2012), 210–218.
15. Kalpana, C., Sudheer, A.R., Rajasekharan, K.N., Menon, V.P., Comparative effects of curcumin and its synthetic analogue on tissue lipid peroxidation and antioxidant status during nicotine-induced toxicity. Singapore Medicinal Journal 48 (2007), 124–130.
16. Kanai, M., Imaizumi, A., Otsuka, Y., Sasaki, H., Hashiguchi, M., Tsujiko, K.,.. Chiba, T., Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers. Cancer Chemotherapy and Pharmacology 69 (2012), 65–70.
17. Kroyer, G., Stevioside and Stevia-sweetener in food: Application, stability and interaction with food ingredients. Journal of Consumer Protection and Food Safety 5 (2010), 225–229.
18. Lao, C.D., Ruffin, M.T.T., Normolle, D., Heath, D.D., Murray, S.I., Bailey, J.M.,.. Brenner, D.E., Dose escalation of a curcuminoid formulation. BMC Complementary and Alternative Medicine, 6, 2006, 10.
19. Letchford, K., Liggins, R., Burt, H., Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: Theoretical and experimental data and correlations. Journal of Pharmaceutical Sciences 97 (2008), 1179–1190.
20. Li, L., Braiteh, F.S., Kurzrock, R., Liposome-encapsulated curcumin: In vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104 (2005), 1322–1331.
21. Lin, X.H., Ji, S., Qiao, X., Hu, H.B., Chen, N., Dong, Y.H.,.. Ye, M., Density functional theory calculations in stereochemical determination of rerpecurcumins J-W, cytotoxic terpene-conjugated curcuminoids from Curcuma longa L. Journal of Organic Chemistry 78 (2013), 11835–11848.
22. Liu, A., Lou, H., Zhao, L., Fan, P., Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin. Journal of Pharmaceutical Biomedical Analysis 40 (2006), 720–727.
23. Murdock, R.C., Braydich-Stolle, L., Schrand, A.M., Schlager, J.J., Hussain, S.M., Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicological Sciences 101 (2008), 239–253.
24. Nguyen, T.T., Jung, S.J., Kang, H.K., Kim, Y.M., Moon, Y.H., Kim, M., Kim, D., Production of rubusoside from stevioside by using a thermostable lactase from Thermus thermophilus and solubility enhancement of liquiritin and teniposide. Enzyme Microbial Technology 64–65 (2014), 38–43.
25. Nguyen, T.T.H., Lee, S., Wang, H.K., Chen, H.Y., Wu, Y.T., Lin, S.C.,.. Kim, D., In vitro evaluation of novel inhibitors against the NS2B-NS3 protease of dengue fever virus type 4. Molecules 18 (2013), 15600–15612.
26. Nishiyama, T., Mae, T., Kishida, H., Tsukagawa, M., Mimaki, Y., Kuroda, M.,.. Kitahara, M., Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. Journal of Agriculture and Food Chemistry 53 (2005), 959–963.
27. Ohori, H., Yamakoshi, H., Tomizawa, M., Shibuya, M., Kakudo, Y., Takahashi, A.,.. Shibata, H., Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer. Molecular Cancer Therapeutics 5 (2006), 2563–2571.
28. Ponnusamy, S., Zinjarde, S., Bhargava, S., Rajamohanan, P.R., Ravikumar, A., Discovering Bisdemethoxycurcumin from Curcuma longa rhizome as a potent small molecule inhibitor of human pancreatic alpha-amylase, a target for type-2 diabetes. Food Chemistry 135 (2012), 2638–2642.
29. Priyadarsini, K.I., The chemistry of curcumin: From extraction to therapeutic Agent. Molecules 19 (2014), 20091–20112.
30. Salmaso, S., Bersani, S., Semenzato, A., Caliceti, P., New cyclodextrin bioconjugates for active tumour targeting. Journal of Drug Targeting 15 (2007), 379–390.
31. Sandur, S.K., Pandey, M.K., Sung, B., Ahn, K.S., Murakami, A., Sethi, G.,.. Aggarwal, B.B., Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 28 (2007), 1765–1773.
32. Sasaki, H., Sunagawa, Y., Takahashi, K., Imaizumi, A., Fukuda, H., Hashimoto, T.,.. Morimoto, T., Innovative preparation of curcumin for improved oral bioavailability. Biological and Pharmaceutical Bulletin 34 (2011), 660–665.
33. Savjani, K.T., Gajjar, A.K., Savjani, J.K., Drug solubility: Importance and enhancement techniques. ISRN Pharmaceutics, 2012, 2012, 195727.
34. Shoba, G., Joy, D., Joseph, T., Majeed, M., Rajendran, R., Srinivas, P.S., Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica 64 (1998), 353–356.
35. Simon, A., Allais, D.P., Duroux, J.L., Basly, J.P., Durand-Fontanier, S., Delage, C., Inhibitory effect of curcuminoids on MCF-7 cell proliferation and structure-activity relationships. Cancer Letters 129 (1998), 111–116.
36. Somparn, P., Phisalaphong, C., Nakornchai, S., Unchern, S., Morales, N.P., Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biological Pharmaceutical Bulletin 30 (2007), 74–78.
37. Syu, W.J., Shen, C.C., Don, M.J., Ou, J.C., Lee, G.H., Sun, C.M., Cytotoxicity of curcuminoids and some novel compounds from Curcuma zedoaria. Journal of Natural Products 61 (1998), 1531–1534.
38. Upreti, M., Strassburger, K., Chen, Y.L., Wu, S.X., Prakash, I., Solubility Enhancement of steviol glycosides and characterization of their inclusion complexes with gamma-cyclodextrin. International Journal of Molecular Sciences 12 (2011), 7529–7553.
39. Wang, Y.J., Pan, M.H., Cheng, A.L., Lin, L.I., Ho, Y.S., Hsieh, C.Y., Lin, J.K., Stability of curcumin in buffer solutions and characterization of its degradation products. Journal of Pharmaceutical and Biomedical Analysis 15 (1997), 1867–1876.
40. Zhang, F., Koh, G.Y., Jeansonne, D.P., Hollingsworth, J., Russo, P.S., Vicente, G.,.. Liu, Z., A novel solubility-enhanced curcumin formulation showing stability and maintenance of anticancer activity. Journal of Pharmaceutical Sciences 100 (2011), 2778–2789.